Dataset Information
Vogt-Koyanagi-Harada-Like Disease with Loss of Visual Acuity due to Sunitinib Treatment Restored after Switch in Therapy: A Case Report.
Ontology highlight
ABSTRACT: Introduction
In this paper, we report a case of visual impairment during treatment with sunitinib in a patient with metastatic renal cell carcinoma.Methods
Retrospective chart review was used.Case presentation
We describe a 74-year-old male with metastatic renal cell carcinoma who was treated with sunitinib and experienced severe loss of visual acuity due to serous retinal detachment and intraretinal fluid. Upon discontinuation of sunitinib, the retinal fluid resolved, and visual acuity was restored.Conclusion
Serous retinal detachment has been described as a side effect of sunitinib use. Discontinuing sunitinib promptly resolved the subretinal fluid collections and restored vision.
SUBMITTER: van Olden MCS
PROVIDER: S-EPMC10919912 | biostudies-literature | 2024 Jan-Dec
REPOSITORIES: biostudies-literature
Publications
Vogt-Koyanagi-Harada-Like Disease with Loss of Visual Acuity due to Sunitinib Treatment Restored after Switch in Therapy: A Case Report.
Case reports in ophthalmology 20240101 1
<h4>Introduction</h4>In this paper, we report a case of visual impairment during treatment with sunitinib in a patient with metastatic renal cell carcinoma.<h4>Methods</h4>Retrospective chart review was used.<h4>Case presentation</h4>We describe a 74-year-old male with metastatic renal cell carcinoma who was treated with sunitinib and experienced severe loss of visual acuity due to serous retinal detachment and intraretinal fluid. Upon discontinuation of sunitinib, the retinal fluid resolved, an ...[more]